chloroxine has been researched along with tanshinone ii a sodium sulfonate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y; Jadhav, P; Tan, B; Tan, H; Wang, J | 1 |
| Chen, K; Chen, X; Fang, L; Lei, Y; Ma, Y; Pan, J; Tang, J; Xu, W; Xu, Y; Zhan, J; Zhang, B; Zhang, D; Zheng, Y; Zhou, Y | 1 |
1 review(s) available for chloroxine and tanshinone ii a sodium sulfonate
| Article | Year |
|---|---|
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease.
Topics: Antiviral Agents; Coronavirus Papain-Like Proteases; COVID-19 Drug Treatment; Humans; Pandemics; Protease Inhibitors; SARS-CoV-2 | 2022 |
1 other study(ies) available for chloroxine and tanshinone ii a sodium sulfonate
| Article | Year |
|---|---|
Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease.
Topics: Antiviral Agents; Binding Sites; Chloroquinolinols; Coronavirus Papain-Like Proteases; Coronavirus Protease Inhibitors; COVID-19 Drug Treatment; Drug Repositioning; High-Throughput Screening Assays; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Phenanthrenes; SARS-CoV-2 | 2021 |